Abstract
There is concern about coronary heart disease (CHD) in the HIV-infected population using antiretrovirals. Across Europe and North America, this population is at a higher risk of myocardial infarction (MI) than the general population [1–3], although the difference seems to diminish in recent years [4]. Consequently, identifying HIV-infected individuals at risk for CHD, and more broadly for all atherosclerotic cardiovascular disease (ASCVD) events including CHD and stroke, is desirable albeit extremely challenging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
